Riskpilot← Back to searchSign inGet full accessDW Medical AB
ABActiveOrg 5567374029Rådhustorget 5 BGeneral medical practice activities · NACE 8621Est. 20071-4 employees
Revenue 2024
SEK 4,8M
-10% vs 2023
EBITDA margin
81.6%
+609% vs 2023
Equity ratio
57.5%
Financial strength
Net profit 2024
SEK 5,1M
+954% vs 2023
| Revenue | SEK 4,8M | -10% |
| EBITDA | SEK 3,9M | +609% |
| Net profit | SEK 5,1M | +954% |
| Total assets | SEK 10M | -5% |
| Equity | SEK 5,7M | +250% |
| Employees | — | — |
Legal name
DW Medical AB
Org number
5567374029
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
11 september 2007
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva läkarvård, hälsovård, läkemedelsprov, försäljning av läkemedel, konsultverksamhet, kursverksamhet, föreläsningar, internationell kontakt inom medicinsk verksamhet, import- och export inom hälso- och sjukvård, teknik- och miljöprodukter, möbler och hushållsprodukter samt därmed förenlig verksamhet.
Address
Rådhustorget 5 B
Email
info@drwang.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 641 | 5 992 | 6 337 | 5 303 | 4 766 |
| Staff expenses | — | — | −2 514 | −2 871 | −2 251 |
| EBITDA | 2 039 | 2 157 | 1 884 | 549 | 3 890 |
| Depreciation & amort. | −204 | −277 | −270 | −234 | −83 |
| EBIT | 1 835 | 1 880 | 1 615 | 315 | 3 808 |
| Net financials | −1 | −1 | 3 | 82 | 139 |
| Profit before tax | 1 692 | 1 825 | 1 803 | 701 | 5 648 |
| Tax | −422 | −462 | −451 | −218 | −557 |
| Net profit | 1 270 | 1 363 | 1 352 | 483 | 5 090 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 10 509 | 11 691 | 11 302 | 10 530 | 9 963 |
| Equity | 2 437 | 3 100 | 2 452 | 1 635 | 5 725 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 464 | 630 | 777 | 828 | 962 |
| Total debt | 464 | 630 | 777 | 828 | 962 |
EBITDA margin
81.6%
This company
15.8%
Market median
+416% vs market
20202024
Equity ratio
57.5%
This company
38.2%
Market median
+51% vs market
20202024
Return on equity
88.9%
This company
18.4%
Market median
+383% vs market
20202024
Net profit margin
106.8%
This company
8.1%
Market median
+1219% vs market
20202024
Asset turnover
0.48×
This company
1.12×
Market median
-57% vs market
20202024
Debt / equity
0.74×
This company
0.62×
Market median
+19% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TM Audit | Audit | 2026 |
AC | Audit | 2025 |
| Former (2) | ||
OJ Audit | Audit | 2020 – 2025 |
SM Auditor Substitute | Auditor Substitute | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Deputy Board Member | 2025 | |
| Former (2) | ||
| Deputy Board Member | 2020 – 2025 | |
| Board of Directors | 2020 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Centrum För Andrologi och Urologi i Sverige AB
DW Medical AB Board members of DW Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tony Mikael Salonen | Audit | 0 companies |
| Ola Johan Hulldin | Audit | 0 companies |
| Stefan Mikael Bengtsson | Auditor Substitute | 0 companies |
| Anders Christian Dahlström | Audit | 0 companies |
| Navid Mohammad Tajhizi | Board of Directors | 0 companies |
| Xiumei Zhang | Deputy Board Member | 0 companies |
| Eugen Yuhui Wang | Board of Directors | 0 companies |
| Charlotta Viktoria Sofie Helgesen | Deputy Board Member | 0 companies |